<!DOCTYPE html>

<html>

<head>

<meta charset="utf-8" />
<meta name="generator" content="pandoc" />
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />




<title>Robust exchangeability and bioequivalence studies</title>

<script src="site_libs/header-attrs-2.18/header-attrs.js"></script>
<script src="site_libs/jquery-3.6.0/jquery-3.6.0.min.js"></script>
<meta name="viewport" content="width=device-width, initial-scale=1" />
<link href="site_libs/bootstrap-3.3.5/css/bootstrap.min.css" rel="stylesheet" />
<script src="site_libs/bootstrap-3.3.5/js/bootstrap.min.js"></script>
<script src="site_libs/bootstrap-3.3.5/shim/html5shiv.min.js"></script>
<script src="site_libs/bootstrap-3.3.5/shim/respond.min.js"></script>
<style>h1 {font-size: 34px;}
       h1.title {font-size: 38px;}
       h2 {font-size: 30px;}
       h3 {font-size: 24px;}
       h4 {font-size: 18px;}
       h5 {font-size: 16px;}
       h6 {font-size: 12px;}
       code {color: inherit; background-color: rgba(0, 0, 0, 0.04);}
       pre:not([class]) { background-color: white }</style>
<script src="site_libs/navigation-1.1/tabsets.js"></script>
<link href="site_libs/highlightjs-9.12.0/default.css" rel="stylesheet" />
<script src="site_libs/highlightjs-9.12.0/highlight.js"></script>
<link rel="shortcut icon" type="image/png" href="images/favicon.png">

<!-- Global site tag (gtag.js) - Google Analytics -->
<script async src="https://www.googletagmanager.com/gtag/js?id=UA-167561397-1"></script>
<script>
  window.dataLayer = window.dataLayer || [];
  function gtag(){dataLayer.push(arguments);}
  gtag('js', new Date());

  gtag('config', 'UA-167561397-1');
</script>

<style type="text/css">
  code{white-space: pre-wrap;}
  span.smallcaps{font-variant: small-caps;}
  span.underline{text-decoration: underline;}
  div.column{display: inline-block; vertical-align: top; width: 50%;}
  div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
  ul.task-list{list-style: none;}
    </style>

<style type="text/css">code{white-space: pre;}</style>
<script type="text/javascript">
if (window.hljs) {
  hljs.configure({languages: []});
  hljs.initHighlightingOnLoad();
  if (document.readyState && document.readyState === "complete") {
    window.setTimeout(function() { hljs.initHighlighting(); }, 0);
  }
}
</script>





<style type="text/css">
/* for pandoc --citeproc since 2.11 */
div.csl-bib-body { }
div.csl-entry {
  clear: both;
}
.hanging div.csl-entry {
  margin-left:2em;
  text-indent:-2em;
}
div.csl-left-margin {
  min-width:2em;
  float:left;
}
div.csl-right-inline {
  margin-left:2em;
  padding-left:1em;
}
div.csl-indent {
  margin-left: 2em;
}
</style>

<link rel="stylesheet" href="bootstrap.css" type="text/css" />



<style type = "text/css">
.main-container {
  max-width: 940px;
  margin-left: auto;
  margin-right: auto;
}
img {
  max-width:100%;
}
.tabbed-pane {
  padding-top: 12px;
}
.html-widget {
  margin-bottom: 20px;
}
button.code-folding-btn:focus {
  outline: none;
}
summary {
  display: list-item;
}
details > summary > p:only-child {
  display: inline;
}
pre code {
  padding: 0;
}
</style>


<style type="text/css">
.dropdown-submenu {
  position: relative;
}
.dropdown-submenu>.dropdown-menu {
  top: 0;
  left: 100%;
  margin-top: -6px;
  margin-left: -1px;
  border-radius: 0 6px 6px 6px;
}
.dropdown-submenu:hover>.dropdown-menu {
  display: block;
}
.dropdown-submenu>a:after {
  display: block;
  content: " ";
  float: right;
  width: 0;
  height: 0;
  border-color: transparent;
  border-style: solid;
  border-width: 5px 0 5px 5px;
  border-left-color: #cccccc;
  margin-top: 5px;
  margin-right: -10px;
}
.dropdown-submenu:hover>a:after {
  border-left-color: #adb5bd;
}
.dropdown-submenu.pull-left {
  float: none;
}
.dropdown-submenu.pull-left>.dropdown-menu {
  left: -100%;
  margin-left: 10px;
  border-radius: 6px 0 6px 6px;
}
</style>

<script type="text/javascript">
// manage active state of menu based on current page
$(document).ready(function () {
  // active menu anchor
  href = window.location.pathname
  href = href.substr(href.lastIndexOf('/') + 1)
  if (href === "")
    href = "index.html";
  var menuAnchor = $('a[href="' + href + '"]');

  // mark the anchor link active (and if it's in a dropdown, also mark that active)
  var dropdown = menuAnchor.closest('li.dropdown');
  if (window.bootstrap) { // Bootstrap 4+
    menuAnchor.addClass('active');
    dropdown.find('> .dropdown-toggle').addClass('active');
  } else { // Bootstrap 3
    menuAnchor.parent().addClass('active');
    dropdown.addClass('active');
  }

  // Navbar adjustments
  var navHeight = $(".navbar").first().height() + 15;
  var style = document.createElement('style');
  var pt = "padding-top: " + navHeight + "px; ";
  var mt = "margin-top: -" + navHeight + "px; ";
  var css = "";
  // offset scroll position for anchor links (for fixed navbar)
  for (var i = 1; i <= 6; i++) {
    css += ".section h" + i + "{ " + pt + mt + "}\n";
  }
  style.innerHTML = "body {" + pt + "padding-bottom: 40px; }\n" + css;
  document.head.appendChild(style);
});
</script>

<!-- tabsets -->

<style type="text/css">
.tabset-dropdown > .nav-tabs {
  display: inline-table;
  max-height: 500px;
  min-height: 44px;
  overflow-y: auto;
  border: 1px solid #ddd;
  border-radius: 4px;
}

.tabset-dropdown > .nav-tabs > li.active:before, .tabset-dropdown > .nav-tabs.nav-tabs-open:before {
  content: "\e259";
  font-family: 'Glyphicons Halflings';
  display: inline-block;
  padding: 10px;
  border-right: 1px solid #ddd;
}

.tabset-dropdown > .nav-tabs.nav-tabs-open > li.active:before {
  content: "\e258";
  font-family: 'Glyphicons Halflings';
  border: none;
}

.tabset-dropdown > .nav-tabs > li.active {
  display: block;
}

.tabset-dropdown > .nav-tabs > li > a,
.tabset-dropdown > .nav-tabs > li > a:focus,
.tabset-dropdown > .nav-tabs > li > a:hover {
  border: none;
  display: inline-block;
  border-radius: 4px;
  background-color: transparent;
}

.tabset-dropdown > .nav-tabs.nav-tabs-open > li {
  display: block;
  float: none;
}

.tabset-dropdown > .nav-tabs > li {
  display: none;
}
</style>

<!-- code folding -->




</head>

<body>


<div class="container-fluid main-container">




<div class="navbar navbar-default  navbar-fixed-top" role="navigation">
  <div class="container">
    <div class="navbar-header">
      <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-bs-toggle="collapse" data-target="#navbar" data-bs-target="#navbar">
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
      </button>
      <a class="navbar-brand" href="index.html"><img id="logo" style="position:absolute; top:5px; height: 60px;" src="images/logo.png"/></a>
    </div>
    <div id="navbar" class="navbar-collapse collapse">
      <ul class="nav navbar-nav">
        
      </ul>
      <ul class="nav navbar-nav navbar-right">
        <li>
  <a href="index.html">Home</a>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    Services
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="01_01_bayesian_approach.html">Bayesian Approach</a>
    </li>
    <li>
      <a href="01_02_adaptive_design.html">Adaptive Design</a>
    </li>
    <li>
      <a href="01_03_quantitative_decision_making.html">Quantitative Decision-Making</a>
    </li>
    <li>
      <a href="01_04_biometrics_services.html">Biometrics Services</a>
    </li>
    <li>
      <a href="01_05_r_clinical_reporting.html">R-based solutions for clinical reporting</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    Blog
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="02_04_sample_size_allocation_ratio_prior_information.html">Sample size, allocation ratio and prior information</a>
    </li>
    <li>
      <a href="02_03_delayed_treatment_effect_time_to_event_analyses.html">Delayed treatment effect in time-to-event endpoint</a>
    </li>
    <li>
      <a href="02_02_reproducible_reports_R.html">Reproducible reports with R</a>
    </li>
    <li>
      <a href="02_01_tfls_with_R.html">Tables, figures and listings with R</a>
    </li>
  </ul>
</li>
<li>
  <a href="03_about_me.html">About Me</a>
</li>
<li>
  <a href="04_ressources.html">Ressources</a>
</li>
<li>
  <a href="05_contact.html">Contact</a>
</li>
      </ul>
    </div><!--/.nav-collapse -->
  </div><!--/.container -->
</div><!--/.navbar -->
<p><br><br></p>

<div id="header">




</div>


<script type="text/x-mathjax-config">
    MathJax.Hub.Config({ TeX: { equationNumbers: {autoNumber: "all"} } });
</script>
<p><em>¡Under construction!</em></p>
<div id="robust-exchangeability-and-bioequivalence-studies"
class="section level1">
<h1>Robust exchangeability and bioequivalence studies</h1>
<p>Let’s consider that a reference drug formulation has already been
evaluated in multiple clinical trials. Pharamacokinetic (PK) profile is
considered to be established and information on the main PK parameters,
like the area under the plasma concentation time curve (<span
class="math inline">\(AUC\)</span>), the peak drug concentration <span
class="math inline">\(C_{max}\)</span> or the half-life <span
class="math inline">\(t_{1/2}\)</span>, is readily available.</p>
<p>Due to development constraints, like a modification of the
manufacturing of the active ingredient, a process improvement for
scaling-up the drug production or a new formulation to limit the food
effect, a new formulation is to be evaluated for being used in all
subsequent clinical trials.</p>
<p>Bioequivalence between the reference drug formulation and the new
drug formulation is generally left to the judgment of the sponsor.
According to the FDA guidance on bioavailability and bioequivalence for
studies submitted in NDAs or INDs, <em>bioequivalence means the absence
of a significant difference in the rate and extent to which the active
ingredient or active moiety in pharmaceutical equivalents or
pharmaceutical alternatives become available at the site of drug action
when administered at the same molar dose under similar conditions in an
appropriately designed study</em> (see definition in see <span
class="citation">U.S. Food &amp; Drug Administration - Center for Drug
Evaluation and Research (2014)</span>).</p>
<p>This blog post will assess the impact of the robust exchangeability
approach introduced by <span class="citation">Neuenschwander et al.
(2016)</span> when evaluating the average bioequivalence in a
bioequivalence study.</p>
<p><br></p>
<div id="sec:proposed_approach" class="section level2">
<h2>1. Proposed approach</h2>
<p><br></p>
<div id="average-bioequivalence" class="section level3">
<h3>1.1. Average bioequivalence</h3>
<p>The most commonly used statistical design for comparing a new drug
formulation and a reference drug formulation for average bioequivalence
is a crossover design. At least two sequences and two periods have to be
considered (standard 2x2 crossover design). In a standard 2x2 crossover
design, each subject is randomized and assigned to a sequence of
formulations. Subjects assigned to reference formulation/new formulation
(R/N) will receive R in the first dosing period and N in the second
dosing period. Subjects assigned to new formulation/reference
formulation (N/R) will receive N in the first dosing period and R in the
second dosing period. A sufficiently long washout period is to be
imposed between the two dosing periods.</p>
<center>
<div>
<p><img src="images/crossover_graph.png" alt = "2x2 crossover scheme" style = "margin-top: 10px; margin-bottom: 10px;"></p>
</div>
</center>
<p>Given that PK parameters are (usually) log-normally distributed,
log-transformation of exposure measures before statistical analysis is
recommended <span class="citation">(U.S. Food &amp; Drug Administration
- Center for Drug Evaluation and Research 2001, 2014)</span>. We are
here not discussing how those PK parameters are derived. Please refer to
<span class="citation">Rosenbaum (2016)</span> for a general
introduction on pharmacokinetics.</p>
<p>Let <span class="math inline">\(y_{n}\)</span> be the log of <span
class="math inline">\(n\)</span>-th measure of the PK parameter, <span
class="math inline">\(n=1,\ldots,N\)</span>. The linear model under the
2x2 crossover design can be written as:</p>
<p><span class="math display">\[\begin{equation}
  y_{n} = \alpha_{f_{n}} + \beta \times p_{n} + \gamma \times c_{n} +
\delta_{s_{n}} + \epsilon_{n}
  \label{eq:equation1}
\end{equation}\]</span></p>
<p>where:</p>
<ul>
<li><span class="math inline">\(f_{n}\)</span> is the formulation
indicator, i.e. <span class="math inline">\(1\)</span> or <span
class="math inline">\(2\)</span> if the <span
class="math inline">\(n\)</span>-th observation is under the reference
or new formulation;</li>
<li><span class="math inline">\(p_{n}\)</span> is the period covariate,
i.e. <span class="math inline">\(-1\)</span> or <span
class="math inline">\(+1\)</span> if the <span
class="math inline">\(n\)</span>-th observation is under the period 1 or
period 2;</li>
<li><span class="math inline">\(c_{n}\)</span> is the carry-over
covariate, i.e. <span class="math inline">\(0\)</span> if the <span
class="math inline">\(n\)</span>-th observation is under period 1, <span
class="math inline">\(-1\)</span> if the <span
class="math inline">\(n\)</span>-th observation is under period 2 and
the reference formulation or <span class="math inline">\(+1\)</span> if
the <span class="math inline">\(n\)</span>-th observation is under
period 2 and the new formulation;</li>
<li><span class="math inline">\(s_{n}\)</span> is the subject indicator,
i.e. the subject number associated with the <span
class="math inline">\(n\)</span>-th observation;</li>
<li><span class="math inline">\(\alpha_{1}\)</span> and <span
class="math inline">\(\alpha_{2}\)</span> is the fixed effect for the
reference formulation and the new formulation;</li>
<li><span class="math inline">\(\beta\)</span> is the period
effect;</li>
<li><span class="math inline">\(\gamma\)</span> is the carry-over
effect;</li>
<li><span class="math inline">\(\delta_{s_{n}}\)</span> is the random
effect of the <span class="math inline">\(s_{n}\)</span>-th subject,
normally distributed with mean 0 and variance <span
class="math inline">\(\sigma_{s}^{2}\)</span>;</li>
<li><span class="math inline">\(\epsilon_{n}\)</span> is the random
error in observing <span class="math inline">\(y_{n}\)</span>, normally
distributed with mean 0 and variance <span
class="math inline">\(\sigma_{\epsilon,f_n}^{2}\)</span>;</li>
<li>the random effect and the random error are mutually
independent.</li>
</ul>
<p>The average bioequivalence will be stated if the 90% credible
interval for <span class="math inline">\(\alpha_{2} -
\alpha_{1}\)</span> is contained in the interval <span
class="math inline">\(\left[-\log\left(1.25\right);
\log\left(1.25\right)\right]\)</span>.</p>
<p><br></p>
</div>
<div id="robust-exchangeability" class="section level3">
<h3>1.2. Robust exchangeability</h3>
<p><span class="citation">Neuenschwander et al. (2016)</span> have
proposed a exchangeability–nonexchangeability (EXNEX) approach that can
be seen as a robust mixture extension of the standard exchangeability
approach. Each stratum-specific parameter can be exchangeable with other
similar strata parameters or nonexchangeable with any of them.</p>
<p>The idea is to adapt this approach to the average bioequivalence
setting and to apply the EXNEX approach on being under the reference
drug formulation or the new drug formulation. For formulation <span
class="math inline">\(i\)</span>, the fixed effect <span
class="math inline">\(\alpha_{i}\)</span> is modelled by:</p>
<ul>
<li>Exchangeability component, with probability <span
class="math inline">\(\pi_{i}\)</span>:
<ul>
<li><span class="math inline">\(\alpha_{i}|\mu_{\alpha},\tau_{\alpha}
\sim
\mathcal{N}\left(\mu_{\alpha},\tau_{\alpha}^{2}\right)\)</span>;</li>
<li><span class="math inline">\(\mu_{\alpha} \sim
\mathcal{N}\left(m_{\alpha},t_{\alpha}^{2}\right)\)</span>;</li>
<li><span class="math inline">\(\tau_{\alpha} \sim
\mathcal{HN}\left(0,\nu_{\alpha}^{2}\right)\)</span>;</li>
</ul></li>
<li>Non-exchangeability component, with probability <span
class="math inline">\(1 - \pi_{i}\)</span>:
<ul>
<li><span class="math inline">\(\alpha_{i} \sim
\mathcal{N}\left(m_{\alpha_{i}},t_{\alpha_{i}}^{2}\right)\)</span>.</li>
</ul></li>
</ul>
<p>For the exchangeability distribution, parameters for the prior
distributions for <span class="math inline">\(\mu_{\alpha}\)</span> and
<span class="math inline">\(\tau_{\alpha}\)</span> will be constructed
based on the available information from all the clinical trials where PK
information is available on the reference drug formulation. For the
non-exchangeable distribution, weakly informative prior could be
envisaged. The probability <span class="math inline">\(\pi_{i}\)</span>
can either be fixed and will be updated during the estimation process or
a prior distribution can be set on it, e.g. <span
class="math inline">\(\pi_{i} \sim \mathcal{Be}\left(a_{i},
b_{i}\right)\)</span>. In both situation, it will indicate how a priori
the reference/new drug formulations are exchangeable.</p>
<p>Supplementary material from <span class="citation">Neuenschwander et
al. (2016)</span> provides the WinBUGS <span class="citation">(Lunn et
al. 2000)</span> code for the binary EXNEX model. This can easily be
updated to the 2x2 crossover linear model and over other software like
Stan <span class="citation">(Stan Development Team 2018)</span>.</p>
<p><br></p>
</div>
</div>
<div id="simulation" class="section level2">
<h2>2. Simulation</h2>
<p><br></p>
<div id="simulation-scenarios" class="section level3">
<h3>2.1. Simulation scenarios</h3>
<p>In order to evaluate the characteristics for the proposed robust
exchangeability approach, simulations will be performed over multiple
scenarios. Without loss of generality, an approach without period
effect, nor carry-over effect will be considered. In addition,
homoscedasticity across the formulations will be considered for the
error term <span class="math inline">\(\epsilon_{n}\)</span>.</p>
<p>The following models will be considered:</p>
<ul>
<li>Robust exchangeability approach presented in <a
href="#sec:proposed_approach">Section 1</a>;</li>
<li>Fully exchangeable approach for the prior for <span
class="math inline">\(\alpha_{i}\)</span>;</li>
<li>Weakly informative approach for the prior for <span
class="math inline">\(\alpha_{i}\)</span>.</li>
</ul>
<p>For the exchangeability distribution, it will not be discussed on how
to set the parameters of the priors for <span
class="math inline">\(\mu_{\alpha}\)</span> and <span
class="math inline">\(\tau_{\alpha}\)</span>. For the simulation, the
followings is assumed:</p>
<ul>
<li><span class="math inline">\(\mu_{\alpha} \sim
\mathcal{N}\left(1,0.1^2\right)\)</span></li>
<li><span class="math inline">\(\tau_{\alpha} \sim
\mathcal{HN}\left(0,0.2^2\right)\)</span>.</li>
</ul>
<p>For the exchangeability probability <span
class="math inline">\(\pi_{i}\)</span>, a beta distribution with shape
parameters at 3 and 1 is considered. Mode is at 1, but probability of
that <span class="math inline">\(\pi_{i}\)</span> is below 0.5 is equal
to 0.125, indicating confidence on the exchangeability and</p>
<p>The following data generation process will be considered:</p>
<ul>
<li>Fixed effect for the reference formulation and the new formulation:
<ul>
<li><span class="math inline">\(\alpha_{1}\)</span> set at 1;</li>
<li><span class="math inline">\(\alpha_{2}\)</span> set at 0.5, 1 and
2;</li>
</ul></li>
<li>No period effect;</li>
<li>No carry-over effect;</li>
<li>Standard deviation for the subject random effect set at 0.1;</li>
<li>Standard deviation for the random error set at 0.2 (no formulation
specific standard deviation);</li>
<li>Twelve (12), 16 or 20 subjects.</li>
</ul>
<p>Per data generation scenario, 10’000 datasets will be generated.
Power for average bioequivalence will be estimated as the proportion of
cases where the 90% credible interval for <span
class="math inline">\(\alpha_{2} - \alpha_{1}\)</span> is contained in
the interval <span class="math inline">\(\left[-\log\left(1.25\right);
\log\left(1.25\right)\right]\)</span>.</p>
<p><br></p>
</div>
</div>
<div id="simulation-results" class="section level2">
<h2>2.2. Simulation results</h2>
<p><br></p>
</div>
<div id="conclusion" class="section level2">
<h2>3. Conclusion</h2>
<p>When data generation aligned with prior, robust approach work
similarly to the exchangeable approach When data generation indicates
average bioequivalence but is not aligned with the priors, robust
approach works similarly to the weakly informative prior. When data
generation indicates no average bioequivalence,</p>
<p>Discuss about the possibility to have easily adaptive feature and
predictive probability decision.</p>
<p><br></p>
<p><small><em>Post created on 2020-12-DD. Last update on
2020-12-DD.</em></small></p>
<hr />
<p><br></p>
</div>
</div>
<div id="references" class="section level1">
<h1>References</h1>
<p><small></p>
<div id="refs" class="references csl-bib-body hanging-indent">
<div id="ref-Lunn2000" class="csl-entry">
Lunn, David, Andrew Thomas, Nicky Best, and David Spiegelhalter. 2000.
<span>“<span>WinBUGS</span> - a Bayesian Modelling Framework: Concepts,
Structure, and Extensibility.”</span> <em>Statistics and Computing</em>
10: 325–37. <a
href="https://doi.org/10.1023/A:1008929526011">https://doi.org/10.1023/A:1008929526011</a>.
</div>
<div id="ref-Neuenschwander2016" class="csl-entry">
Neuenschwander, Beat, Simon Wandel, Satrajit Roychoudhury, and Stuart
Bailey. 2016. <span>“Robust Exchangeability Designs for Early Phase
Clinical Trials with Multiple Strata.”</span> <em>Pharmaceutical
Statistics</em> 15 (2): 123–34. https://doi.org/<a
href="https://doi.org/10.1002/pst.1730">https://doi.org/10.1002/pst.1730</a>.
</div>
<div id="ref-rosenbaum2016" class="csl-entry">
Rosenbaum, S. E. 2016. <em>Basic Pharmacokinetics and Pharmacodynamics:
An Integrated Textbook and Computer Simulations</em>. Wiley.
</div>
<div id="ref-sdt2018" class="csl-entry">
Stan Development Team. 2018. <span>“RStan: The r Interface to
Stan.”</span> 2018. <a href="http://mc-stan.org">http://mc-stan.org</a>.
</div>
<div id="ref-FDA2001" class="csl-entry">
U.S. Food &amp; Drug Administration - Center for Drug Evaluation and
Research. 2001. <span>“Statistical Approaches to Establishing
Bioequivalence.”</span> <a
href="https://www.fda.gov/media/70958/download">https://www.fda.gov/media/70958/download</a>.
</div>
<div id="ref-FDA2014" class="csl-entry">
———. 2014. <span>“Bioavailability and Bioequivalence Studies Submitted
in <span>NDAs</span> or <span>INDs</span> - General Considerations
(Draft).”</span> <a
href="https://www.fda.gov/media/88254/download">https://www.fda.gov/media/88254/download</a>.
</div>
</div>
</div>

<p><br><br><br></p>
<p style="text-align:center;">
<a href="mailto:info@jaeger-consulting.io?subject=Request for information"><img src="images/email.png" style="height: 20px;"></a>
<a href="https://www.linkedin.com/company/jaeger-consulting" target="_blank"><img src="images/linkedin_logo.png" style="height: 20px;"></a>
<a href="https://github.com/jaeger-consulting" target="_blank"><img src="images/github_logo.png" style="height: 20px;"></a>
</p>
<p style="text-align:center;"><small>Jaeger Consulting &copy 2023</small></p>



</div>

<script>

// add bootstrap table styles to pandoc tables
function bootstrapStylePandocTables() {
  $('tr.odd').parent('tbody').parent('table').addClass('table table-condensed');
}
$(document).ready(function () {
  bootstrapStylePandocTables();
});


</script>

<!-- tabsets -->

<script>
$(document).ready(function () {
  window.buildTabsets("TOC");
});

$(document).ready(function () {
  $('.tabset-dropdown > .nav-tabs > li').click(function () {
    $(this).parent().toggleClass('nav-tabs-open');
  });
});
</script>

<!-- code folding -->


<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
